GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus. - Wikidata - awgldk - TriplyDB

GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.

GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.

http://www.wikidata.org/entity/Q51361706

about

Regulation of adaptive immunity; the role of interleukin-10 Beta cell antigens in type 1 diabetes: triggers in pathogenesis and therapeutic targets Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes Antigen-based immunotherapy for autoimmune disease: current status Type 1 diabetes Recombinant Lactococcus lactis can make the difference in antigen-specific immune tolerance induction, the Type 1 Diabetes case Vaccine against autoimmune disease: antigen-specific immunotherapy Immune therapy in type 1 diabetes mellitus Type 1 diabetes: translating mechanistic observations into effective clinical outcomes Type 1 diabetes mellitus.Combination therapy with an anti-IL-1β antibody and GAD65 DNA vaccine can reverse recent-onset diabetes in the RIP-GP mouse model.Is HOT a cool treatment for type 1 diabetes?Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials.Antigen-based vs. systemic immunomodulation in type 1 diabetes: the pros and cons.GABAergic system in the endocrine pancreas: a new target for diabetes treatment.Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes.Type 1 diabetes: A predictable disease.Current concepts on the pathogenesis of type 1 diabetes--considerations for attempts to prevent and reverse the disease.HCELL Expression on Murine MSC Licenses Pancreatotropism and Confers Durable Reversal of Autoimmune Diabetes in NOD Mice.MAS-1 adjuvant immunotherapy generates robust Th2 type and regulatory immune responses providing long-term protection from diabetes in late-stage pre-diabetic NOD mice Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8⁺ T cells in type 1 diabetes.Thinking bedside at the bench: the NOD mouse model of T1DM.Topical steroid therapy induces pro-tolerogenic changes in Langerhans cells in human skin.Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.Can we vaccinate against Type 1 diabetes?Current and future immunomodulation strategies to restore tolerance in autoimmune diseases.Galantamine Attenuates Type 1 Diabetes and Inhibits Anti-Insulin Antibodies in Non-Obese Diabetic Mice Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis.Mechanistic basis of immunotherapies for type 1 diabetes mellitus Clinical optimization of antigen specific modulation of type 1 diabetes with the plasmid DNA platform.Identification of Candidate Tolerogenic CD8(+) T Cell Epitopes for Therapy of Type 1 Diabetes in the NOD Mouse Model.Heterogeneity in recent-onset type 1 diabetes - a clinical trial perspective Residual beta cell function at diagnosis of type 1 diabetes in children and adolescents varies with gender and season.Protective role of adenovirus vector-mediated interleukin-10 gene therapy on endogenous islet β-cells in recent-onset type 1 diabetes in NOD mice Novel autoantigens in type 1 diabetes.Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.Non-antigenic and antigenic interventions in type 1 diabetes Potential beneficial effects of a gluten-free diet in newly diagnosed children with type 1 diabetes: a pilot study Clinical potential of antigen-specific therapies in type 1 diabetes.Immune Tolerance for Autoimmune Disease and Cell Transplantation

P2860

Q21131215-CF8E75E9-B444-4882-84D1-81EDBE27F288 Q26751244-27CB772A-E6D9-4C94-B18F-F8D7E679A454 Q26770386-0A0A1E22-6521-4F63-A7B5-0F11B36A642D Q26852915-0E28E244-28FB-4628-BEDD-E42908CD7A4D Q27000491-535D5109-5740-4682-8F3C-1151CC2E3FAC Q27028100-BD3AB031-02A9-43D8-8891-CD986AB1B66E Q27028121-4206C439-BC47-4E33-9B97-74F576ECC5D4 Q28282846-71050966-3F14-4600-9EA5-4757C0EE890B Q28287737-A52E9D3C-6266-473A-AC89-233A13F976E4 Q30235021-ED2A2242-9C5A-429D-AF18-6235844810BB Q33646749-9041DCD7-D1A2-4967-9F7B-636CAE3F7EC6 Q34283420-D9CFA6C8-DA8E-4584-B748-1422D615E4A2 Q34318993-A8C14485-C878-4EE4-9F47-4420746EC245 Q34375578-3E647B18-46E2-43FC-BED5-412855CABA20 Q35067598-6432AF70-622A-467E-AC59-9E89489597D1 Q35242428-77709D16-0B99-4955-A5AC-8CB256092BD1 Q35437721-EFB44AB1-DF25-428B-8EF1-49C9D246DA17 Q35630698-D65EB52F-F1D3-4A07-8DA9-64A53C724854 Q35660316-F7B1CDBD-7333-4D82-BF0C-AAE494988A1C Q35891738-8EE5EDFB-1F45-40CF-BAFB-AE2FFD710D9D Q35891952-C4E8635C-4F65-4B51-B6F5-C79457C8D927 Q35911875-196C3486-C17E-4911-81CE-5FCC4BC00019 Q36176416-15C77DE7-B809-4C56-96F4-9E3011B8103F Q36216535-4F10D331-AF08-4C28-875D-2986424FA804 Q36296386-4ACC45F9-B0B9-46B6-B1A9-701A54F23B16 Q36506677-DEEBBFE6-31F0-4F58-A32D-03DED985C180 Q36568311-F9D68E74-CC73-45C4-AFF0-7B9AA4D1D4DD Q36661068-C081C1B8-81C0-43A4-B98A-250B1E149377 Q36698793-823A2E97-39F4-441A-B74D-11886BD3FAA6 Q36709163-0CEBBEA5-6D70-48DF-8E17-FD884C161D74 Q36741859-17F4A1DC-2FC9-44A5-BF65-4295AF745F85 Q36749719-31EB2E14-62E0-42BF-8BA3-41F43A44A9FE Q36818038-F28916DB-0501-4D82-B5D3-7D45FB280338 Q36824703-BD48BF85-73EA-4C5F-B71B-26D0D892CD83 Q36881807-4E86DE57-463C-4569-98D5-BCCD5B3DCB70 Q36913132-E1065F29-6995-4678-8DE7-019976027168 Q36977725-B90CD3BC-A097-4830-A38C-36FE42D9CE91 Q37075420-27B3AE00-C273-44A3-9069-59F564483693 Q37088212-3EDAAB02-8DEE-4AD9-A55E-5A02093FBFCF Q37099107-0D81645F-BEE4-415E-9C3B-C33CAED37794

P2860

GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.

http://www.wikidata.org/entity/Q51361706

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.

@en

GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.

@nl

type

label

GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.

@en

GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.

@nl

prefLabel

GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.

@en

GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.

@nl

P1433

Q51361706-F53090A7-E62C-4979-ADEC-C83BD75C39AF

P1476

Q51361706-FDB6745A-0475-4876-9800-5938CF0E77B2

P2093

Q51361706-02B45928-8D6E-4D17-8BA5-ACE0A4B6B0D0

Q51361706-0AE00462-FF09-47AB-877A-2BFEC1BF5569

Q51361706-0C104895-3895-4396-A35A-C66090EBEC4B

Q51361706-0D00D5C9-5757-4260-B4F8-41708ACC374A

Q51361706-0E365992-A5D7-4CEC-AE9C-57F7F98375AF

Q51361706-0FC77682-68F8-4BED-B2E0-DB0845EB87C6

Q51361706-1213E28A-3F05-4623-B293-002E535432D1

Q51361706-140B7E78-1828-4EB4-9E0B-2A1C87FC8885

Q51361706-148D3EFC-9D90-4CBF-B63E-1513A7DC6F9F

Q51361706-14FAC9E5-23C5-4207-8EF3-F77B8A1ED7DF

P304

Q51361706-AAA2FA10-9A4E-4F9D-8380-D275483DE37C

P31

Q51361706-07217D7C-7002-418F-85D7-7CEF568A1524

P356

Q51361706-3A944E22-6B28-4528-8310-F011B8996D4F

P407

Q51361706-56F2C259-687C-47EF-A4A2-9DE11CAA5376

P433

Q51361706-D05E1478-CC6D-4C6B-A516-574576214346

P478

Q51361706-DCC35912-37C6-4215-BDDB-041925F1F169

P50

Q51361706-06230B90-593F-4C07-854A-102208659B2A

Q51361706-336831A5-3E35-4AD7-8D6D-549696A4F303

Q51361706-8CABC0EB-2D34-482B-A4C4-B98808910062

Q51361706-94253A7C-E503-457A-8B8D-572B3EB39B7A

Q51361706-B7D30069-EA7C-497B-9BDD-86419D6FC5C1

P577

Q51361706-4D915845-9067-4F27-A37A-BDFF8FEAC355

P5875

Q51361706-5D948A3D-17CC-4A3A-A135-E7E33D0193CA

P698

Q51361706-854C1F8E-D62C-4103-9F06-4EE566BAE12F

P921

Q51361706-43CE67C3-F9F2-4F73-8232-3C6A8C64791B

P356

P1433

The New England Journal of Medicine

P1476

GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.

@en

P2093

Alesandro Cicognani

http://www.w3.org/2001/XMLSchema#string

Ana Gomez Gila

http://www.w3.org/2001/XMLSchema#string

Andreas Neu

http://www.w3.org/2001/XMLSchema#string

Anne Marie Bertrand

http://www.w3.org/2001/XMLSchema#string

Annelie Carlsson

http://www.w3.org/2001/XMLSchema#string

Bettina Heidtmann

http://www.w3.org/2001/XMLSchema#string

Björn Rathsman

http://www.w3.org/2001/XMLSchema#string

Carl-Göran Arvidsson

http://www.w3.org/2001/XMLSchema#string

Carl-Göran Åkesson

http://www.w3.org/2001/XMLSchema#string

David Krisky

http://www.w3.org/2001/XMLSchema#string

P304

433-442

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1107096

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

366

http://www.w3.org/2001/XMLSchema#string

P50

Johnny Ludvigsson

Helena Elding Larsson

Tadej Battelino

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221797184

http://www.w3.org/2001/XMLSchema#string

P698

22296077

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes